Clinical Trials Browser

NIH × Sarcoma × Irinotecan × Clear all

NCT01055314 2017-08-29

Temozolomide, Cixutumumab, and Combination Chemotherapy in Treating Patients With Metastatic Rhabdomyosarcoma

Phase 2 Completed

175 enrolled 13 charts

Rhabdomyosarcoma, Sarcoma

NCT00003719 2014-01-06

Irinotecan in Treating Patients With Stage IV or Recurrent Soft Tissue Sarcoma

Phase 2 Unknown

Sarcoma

NCT00276692 2013-06-26

Irinotecan in Treating Patients With Newly Diagnosed Ewing's Sarcoma

Phase 2 Completed

Sarcoma, Neuroectodermal Tumors, Primitive, Peripheral